Every minute in the U.S., a woman requires a blood transfusion because of her period. “Heavy menstrual bleeding affects one in three women, but our resources for treating it are incredibly limited,” said Kathleen O’Neill, MD, an assistant professor of Obstetrics and Gynecology and the program director of the Uterine Transplant Program at the University of Pennsylvania.
Read the full story at : https://www.pennmedicine.org/news/new-research-seeks-an-mrna-therapy-for-heavy-menstrual-bleeding